About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-TE
A14693G
A14693G-F3
A14693G-F2
A14693G-F4
A14693G-F1
A14696G
A14696G-F2
A14696G-F1
C14680A
C14680A-F1
C14701T
C14701T-F1
G14685A
G14685A-F1
G14710A
G14724A
G14739A
T14674C
T14674C-F18
T14674C-F17
T14674C-F16
T14674C-F15
T14674C-F11
T14674C-F3
T14674C-F2
T14674C-F1
T14674G
T14687C
T14709C
T14709C-F10
T14709C-F9
T14709C-F8
T14709C-F7
T14709C-F6
T14709C-F5
T14709C-F4
T14709C-F3
T14709C-F2
T14709C-F1
T14723C
T14723C-F1
T14728C
Edit by Mitofam Team
-
+
首页
G14739A
# **General Information** | **Position** | **14739** | **Variant** | **m.14739G\>A** | **Locus** | **MT\-TE** | **RNA** | **tRNA Glu** | | --- | --- | --- | --- | --- | --- | --- | --- | | **Homoplasmy** | \- | **Heteroplasmy** | \+ | **mitoTIP** | 62\.10% | **Pathogenicity** | Reported \[VUS] | "Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/). # **Pedigree Information** The **m.14739G\>A** variant in MT\-TE has been reported in 1 pedigree. To date, 1 carrier has been reported. Reported mutation loads ranged from 29% to 72%, with a median of 34\.5% overall. In one carrier, a marked tissue\-specific difference was observed, with higher mutation loads in muscle (72%) than in fibroblasts (29%). The main clinical manifestations among affected carriers included No specific clinical features were available for affected carriers.. | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 14739 | m.14739G\>A | G14739A\-F1 | Austria | Slow motor development, poor running ability, appetite loss, weakness, growth retardation, mild muscle atrophy | 0 | 0 | 2006 | [17056256](https://pubmed.ncbi.nlm.nih.gov/17056256/) | | # **Carrier Information** | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 14739 | m.14739G\>A | G14739A\-F1 | G14739A\-F1\-P1 | De novo | F | Y | Y | A | 7 | 31% | 72% | 38% | 29% (F) | Slow motor development, poor running ability, appetite loss, weakness, growth retardation, mild muscle atrophy | | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年6月26日 17:10
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)